These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Endothelial control of vascular smooth muscle proliferation in an organ culture of human saphenous vein. Soyombo AA; Thurston VJ; Newby AC Eur Heart J; 1993 Nov; 14 Suppl I():201-6. PubMed ID: 8293778 [TBL] [Abstract][Full Text] [Related]
3. Interleukin 1 induces prostacyclin-dependent increases in cyclic AMP production and does not affect cyclic GMP production in human vascular smooth muscle cells. Beasley D; McGuiggin ME Cytokine; 1995 Jul; 7(5):417-26. PubMed ID: 7578979 [TBL] [Abstract][Full Text] [Related]
4. Role of phosphodiesterase 3 in NO/cGMP-mediated antiinflammatory effects in vascular smooth muscle cells. Aizawa T; Wei H; Miano JM; Abe J; Berk BC; Yan C Circ Res; 2003 Sep; 93(5):406-13. PubMed ID: 12919948 [TBL] [Abstract][Full Text] [Related]
5. Regulation of contractile activity in vascular smooth muscle by protein kinases. Silver PJ Rev Clin Basic Pharm; 1985; 5(3-4):341-95. PubMed ID: 3029813 [TBL] [Abstract][Full Text] [Related]
6. Regulation and role of guanylate cyclase-cyclic GMP in vascular relaxation. Murad F; Waldman S; Molina C; Bennett B; Leitman D Prog Clin Biol Res; 1987; 249():65-76. PubMed ID: 2890172 [TBL] [Abstract][Full Text] [Related]
7. Altered S-phase kinase-associated protein-2 levels are a major mediator of cyclic nucleotide-induced inhibition of vascular smooth muscle cell proliferation. Wu YJ; Bond M; Sala-Newby GB; Newby AC Circ Res; 2006 May; 98(9):1141-50. PubMed ID: 16574903 [TBL] [Abstract][Full Text] [Related]
8. Modulation of vascular cyclic nucleotide phosphodiesterases by cyclic GMP: role in vasodilatation. Lugnier C; Komas N Eur Heart J; 1993 Nov; 14 Suppl I():141-8. PubMed ID: 8293765 [TBL] [Abstract][Full Text] [Related]
9. Dual functionality of cyclooxygenase-2 as a regulator of tumor necrosis factor-mediated G1 shortening and nitric oxide-mediated inhibition of vascular smooth muscle cell proliferation. Haider A; Lee I; Grabarek J; Darzynkiewicz Z; Ferreri NR Circulation; 2003 Aug; 108(8):1015-21. PubMed ID: 12912810 [TBL] [Abstract][Full Text] [Related]
10. Prostacyclin-induced relaxations of small porcine pulmonary arteries are enhanced by the basal release of endothelium-derived nitric oxide through an effect on cyclic GMP-inhibited-cyclic AMP phosphodiesterase. Zellers TM; Wu YQ; McCormick J; Vanhoutte PM Acta Pharmacol Sin; 2000 Feb; 21(2):131-8. PubMed ID: 11263259 [TBL] [Abstract][Full Text] [Related]
11. Effect of YC-1, an NO-independent, superoxide-sensitive stimulator of soluble guanylyl cyclase, on smooth muscle responsiveness to nitrovasodilators. Mülsch A; Bauersachs J; Schäfer A; Stasch JP; Kast R; Busse R Br J Pharmacol; 1997 Feb; 120(4):681-9. PubMed ID: 9051308 [TBL] [Abstract][Full Text] [Related]
15. Role of protein kinase G in nitric oxide deficiency-induced supersensitivity to nitrovasodilator in rat pulmonary artery. Gupta PK; Subramani J; Singh TU; Leo MD; Sikarwar AS; Prakash VR; Mishra SK J Cardiovasc Pharmacol; 2008 May; 51(5):450-6. PubMed ID: 18418274 [TBL] [Abstract][Full Text] [Related]
16. Regulation of endothelin receptors by nitric oxide in cultured rat vascular smooth muscle cells. Redmond EM; Cahill PA; Hodges R; Zhang S; Sitzmann JV J Cell Physiol; 1996 Mar; 166(3):469-79. PubMed ID: 8600150 [TBL] [Abstract][Full Text] [Related]
17. [Significance of endothelial cells for the regulation of the tone of smooth muscle--formation of an endothelial, relaxing factor]. Förstermann U Z Kardiol; 1986 Oct; 75(10):577-83. PubMed ID: 2878541 [TBL] [Abstract][Full Text] [Related]
19. The mechanisms and significance of the coupled release of endothelium-derived relaxing factor (EDRF) and prostacyclin (PGI2) from endothelial cells. Hyslop S; de Nucci G Wien Klin Wochenschr; 1991; 103(14):422-34. PubMed ID: 1926869 [TBL] [Abstract][Full Text] [Related]